Serial Number
88174398
Owner
Mezzion Pharma Co., Ltd.Attorney
Daniel R. MelloFiling Date
Oct 30, 2018
MEZZION Trademark
Serial Number: 88174398 • Registration: 6115846
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
7F, 570 Samseong-ro, Gangnam-gu
Seoul 06163 , KR
Entity Type: 99
Legal Representation
Correspondence Address
Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP
901 New York Avenue NW
Washington, DC 20001
United States
Trademark Details
Filing Date
October 30, 2018
Registration Date
August 4, 2020
Published for Opposition
May 19, 2020
Goods & Services
Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation ; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others
